| The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19 K Bechman, A Green, MD Russell, Z Yang, B Zheng, S Norton, RM Smith, ... Journal of Infection, 106227, 2024 | | 2024 |
| What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit M Adas, M Dey, S Norton, H Lempp, MH Buch, A Cope, J Galloway, ... RMD open 10 (3), e004180, 2024 | | 2024 |
| BT34 Minimizing drug exposure in psoriasis using a therapeutic drug monitoring dashboard CM Thomas, JF Standing, C Smith, SK Mahil, RB Warren, J Barker, ... British Journal of Dermatology 191 (Supplement_1), i204-i205, 2024 | | 2024 |
| Development and validation of a novel Quality of Life ontology (QoLo), used with natural language processing and online questionnaires to lower existing barriers to developing … CP O'Donovan, S Pendleton, G Curry, S Norton, H Lempp, A Denniston, ... Investigative Ophthalmology & Visual Science 65 (7), 2155-2155, 2024 | | 2024 |
| Acceptability and feasibility randomized controlled trial of a digital psychological support intervention for people with Parkinson’s disease: trial protocol C Pinto, J Brown, C Hurt, S Norton, S Stumpf, R Volpato, P Cubi-Molla, ... | | 2024 |
| Management of refractory disease and persistent symptoms in inflammatory arthritis: qualitative framework analysis of interviews with patients and healthcare professionals H Chaplin, C Simpson, K Wilkins, J Meehan, N Ng, J Galloway, IC Scott, ... Rheumatology Advances in Practice, rkae076, 2024 | | 2024 |
| Mothers in treatment for substance use: using electronic records to understand individual and treatment characteristics Parents in treatment for substance use: using electronic … M Canfield, Z Rehman, S Norton, LPMM Wijlaars, J Downs, G Gilchrist Nuffield Foundation, 2024 | | 2024 |
| Synopsis of manuscript to be submitted to British Journal of Dermatology in September 2022 R Sarkany, J Walburn, R Anderson, V Araujo-Soares, J Boadu, ... Development and evaluation of a personalised psychological intervention to …, 2024 | | 2024 |
| Workstream 2: economic costs of xeroderma pigmentosum R Sarkany, J Walburn, R Anderson, V Araujo-Soares, J Boadu, ... Development and evaluation of a personalised psychological intervention to …, 2024 | | 2024 |
| Workstream 3: consensus conference, intervention design and manual development R Sarkany, J Walburn, R Anderson, V Araujo-Soares, J Boadu, ... Development and evaluation of a personalised psychological intervention to …, 2024 | | 2024 |
| Workstream 4b: process evaluation R Sarkany, J Walburn, R Anderson, V Araujo-Soares, J Boadu, ... Development and evaluation of a personalised psychological intervention to …, 2024 | | 2024 |
| Workstream 2: international cross-sectional survey R Sarkany, J Walburn, R Anderson, V Araujo-Soares, J Boadu, ... Development and evaluation of a personalised psychological intervention to …, 2024 | | 2024 |
| Workstream 1a: qualitative interview study R Sarkany, J Walburn, R Anderson, V Araujo-Soares, J Boadu, ... Development and evaluation of a personalised psychological intervention to …, 2024 | | 2024 |
| Development and evaluation of a personalised psychological intervention to improve adherence to photoprotection in adults with Xeroderma Pigmentosum (XP) R Sarkany, J Walburn, R Anderson, V Araujo-Soares, J Boadu, ... National Institute for Health and Care Research, 2024 | | 2024 |
| Older people's experience recovering from surgery to treat neurogenic claudication. A qualitative study to inform rehabilitation to improve post-operative walking S McIlroy, L Brighton, S Norton, J Weinmann, L Bearne Physiotherapy 123, e54-e55, 2024 | | 2024 |
| AB1343 NO WANING OF PNEUMOCOCCAL VACCINE RESPONSES OVER TIME IN PEOPLE WITH INFLAMMATORY ARTHRITIS: FINDINGS FROM A SINGLE CENTRE COHORT K Bechman, D Nagra, C Baldwin, MA Adas, M Russell, I Karafotias, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 2023-2023, 2024 | | 2024 |
| POS0642 THE IMPACT OF FIBROMYALGIA ON MENTAL HEALTH, QUALITY OF LIFE AND COPING STRATEGIES IN RHEUMATOID ARTHRITIS PATIENTS T Manandhar, M Sweeney, L Carpenter, S De Souza, E Caton, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 776-776, 2024 | | 2024 |
| POS0709 THE RISK OF SERIOUS INFECTIONS IN PATIENTS WITH EARLY INFLAMMATORY ARTHRITIS: RESULTS FROM A LARGE UK COHORT (NEIAA) MA Adas, K Bechman, B Zuckerman, M Russell, S Patel, D Nagra, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 607-608, 2024 | | 2024 |
| POS0903 ABATACEPT AND THE RISK OF MALIGNANCY: A META-ANALYSIS ACROSS DISEASE INDICATIONS B Zuckerman, M Gibson, R Roy, M Hughes, D Mehta, MA Adas, K Ng, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1142-1143, 2024 | | 2024 |
| POS0309-PARE UNDERSTANDING THE PSYCHOSOCIAL DETERMINANTS OF EFFECTIVE DISEASE MANAGEMENT IN RHEUMATOID ARTHRITIS: A QUALITATIVE STUDY N Stoll, M Dey, S Norton, MA Adas, A Bosworth, M Buch, A Cope, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 521-522, 2024 | | 2024 |
James GallowayKing's College LondonVerified email at kcl.ac.uk